Navigation Links
Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer
Date:9/26/2011

/a>.

About Ipsen

Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.1 billion in 2010. Ipsen's ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by four franchises: neurology / Dysport®, endocrinology / Somatuline®, uro-oncology / Decapeptyl® and hemophilia. Moreover, the Group has an active policy of partnerships. R&D is focused on innovative and differentiated technological patient-driven platforms, peptides and toxins. In 2010, R&D expenditure totaled more than €220 million, above 20% of Group sales. The Group has total worldwide staff of close to 4,500 employees. Ipsen's shares are traded on segment A of Euronext Paris (stock code: IPN, ISIN code: FR0010259150) and eligible to the "Service de Règlement Différé" ("SRD"). The Group is part of the SBF 120 index. Ipsen has implemented a Sponsored Level I American Depositary Receipt (ADR) program, which trade on the over-the-counter market in the United States under the symbol IPSEY. For more information on Ipsen, visit http://www.ipsen.com.

References

  1. Jichlinski P et al. J Urol 2003; 170: 226-9
  2. Stenzl. J Urol, 2010; 184: 1907-1914
  3. Jichlinski P et al. J Urol 2003; 170: 226-9
  4. Jocham D et al. J Urol 2005; 174: 862-6
  5. Stenzl A et al. J Urol 2010; 184: 1907-1914


For further information, please contact:

Photocure
President & CEO Kjetil Hestdal
Tel: + 47 913 19 535, Email: kh@photocure.no

CFO Christian Fekete
Tel: + 47 916 42 938, Email: cf@photocure.no

M: Communications

Mary Clark, Amber Bielecka
Tel: +44 207920 2361, Email:

SOURCE Photocure ASA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Photocure Announces Positive Allumera™ Trial Results for Delivering Significant Skin Appearance Improvements
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- Top Staten Island Pediatrician Dr. Michael ... which discusses tips for parents about pool safety for children. ... According to US News article, "Drowning is the ... aged 1 to 4, and can occur in as little ... the article says that watching a child in the water ...
(Date:7/23/2014)... July 23, 2014 PositiveID Corp. (OTCQB: PSID), ... , is an emerging player in the bio-threat ... bio-threat detection and rapid medical testing. The Company,s ... Bio-agent Autonomous Networked Detector), was developed under contract ... Science & Technology directorate, and $30 million of ...
(Date:7/23/2014)... Korea , July 23, 2014  Mezzion Pharma ... program to evaluate the use of udenafil to treat ... single ventricle heart defects. The clinical program will follow ... of the Pediatric Heart Network (PHN), a multi-center clinical ... Blood Institute (NHLBI) of the National Institutes of Health ...
Breaking Medicine Technology:Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com 2Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects 2
... KINGSTOWN, R.I., Sept. 7, 2011 Prescription monitoring ... a new comprehensive program, its Safe Use Treatment ... Management, Safe Use is compliant with the FDA,s ... individual State Prescribing Regulations for controlled substances.  The ...
... NanoSmart™ Pharmaceuticals, Inc., a biopharmaceutical corporation developing ... corporate facility located in Laguna Hills, CA.  The ... necessary to begin formal development of its initial ... us a physical presence in Orange County, California ...
Cached Medicine Technology:Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution 2NanoSmart™ Pharmaceuticals, Inc., Opens New Headquarters - Begins Development of New Drug Delivery Platform for Cancer 2
(Date:7/23/2014)... checking the pulse of a stroke survivor may help ... the method of choice for checking for irregular heartbeat ... a stroke. Our study shows it may be a ... who might need more thorough monitoring to prevent a ... Erlangen University in Germany. The study included ...
(Date:7/23/2014)... Imaging and Bioengineering will host its second Edward C. ... the NIH campus. There will be ten exciting presentations ... NIBIB-funded research. , WHO: , ... Optical Voltage Sensor, Quyen Nguyen, Univ. of California, ... Imaging during Surgery, Jan Grimm, ...
(Date:7/23/2014)... Angeles, CA (PRWEB) July 23, 2014 ... practices delivering Enhanced External Counterpulsation (EECP), is ... who receives EECP therapy at the health center. ... ischemic heart disease. Since receiving ongoing EECP therapy since ... , When Sara Soulati, CEO of Global Cardio Care, ...
(Date:7/23/2014)... Fragile X syndrome ( FXS ) is a ... other behaviors on the autistic spectrum, as well as ... of mental impairment and the most common cause of ... California, Riverside have published a study that ... FXS. Appearing online today (July 23) in the ...
(Date:7/23/2014)... (PRWEB) July 23, 2014 Four hospitals ... been lauded in the latest ranking of the country’s ... . Released online today and slated for publication ... recognizes Allegheny General Hospital (AGH), Forbes Hospital, Saint Vincent ... centers across multiple clinical specialties. , “There ...
Breaking Medicine News(10 mins):Health News:Routine Pulse Check May Prevent Second Stroke, Study Says 2Health News:Global Cardio Care Celebrates EECP Patient’s 100th Birthday 2Health News:Study links enzyme to autistic behaviors 2Health News:Study links enzyme to autistic behaviors 3Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3
... May 21 This year 28 students in 17 states ... sponsored by the Centers for Disease Control and Prevention and ... invites fifth- and sixth-grade students to create posters that encourage ... and the diseases they can cause. Downloadable files of the ...
... 21 For the second year in a row, the ... blood through the Red Cross by joining Red Cross ... Racing is a program designed to increase the number ... Participants of this program can get points for a variety ...
... quarter of those seeking treatment are addicted to the ... -- More pregnant women in drug treatment programs are ... new research shows. , The number of expectant mothers ... 2006. In 1994, methamphetamine use accounted for 8 percent ...
... "Stem cell research and regenerative medicine are in an ... very fast and many companies are being formed and ... Jonas Frisn. , As an example, a first-in-human study ... drug product, sNN0031, from the Swedish company NeuroNova. The ...
... May 21 Three HealthEast hospitals in the ... the federal government a total of $2.28 million ... Medicare fraud involving a certain type of spinal ... first hospitals to settle charges stemming from a ...
... researchers have found that bipolar disorder is more costly ... or coronary artery disease. These findings are based on ... costs (the costs of seeing any specialist and all ... of this review are being presented today at the ...
Cached Medicine News:Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 2Health News:'Fight the Bite' Poster Contest Honors 28 Students in 17 States 3Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 2Health News:NASCAR Fans Boost Blood Donations; The American Red Cross Joins 3M and Greg Biffle to Kick off Season Two 3Health News:Methamphetamine Use Triples Among Pregnant Rehab Patients 2Health News:Methamphetamine Use Triples Among Pregnant Rehab Patients 3Health News:Minnesota Hospitals Pay $2.28 Million to Settle Medicare Fraud Charges Involving Kyphoplasty 2Health News:Minnesota Hospitals Pay $2.28 Million to Settle Medicare Fraud Charges Involving Kyphoplasty 3
... supports interventional cardioangiography procedures with MR imaging ... cardioangiography system., Utilize your angio and MR ... our integrated suite. Because the systems can ... diagnosis and follow-up in one room, one ...
... a comprehensive medical billing software capable ... multiple payer requirements of healthcare billing ... functionality to necessary to process claims ... such as trip reporting for ambulance ...
... code the charge while completing a chart note, ... from office, both directly feeding the charge entry ... Form/Superbill, data entry can be done with our ... are posted by reflecting open item charges, and ...
The HearTwave system is the original stand-alone Microvolt T-Wave Alternans (MTWA) testing platform....
Medicine Products: